Wednesday, May 1, 2013
Harley Y. Tse
Wayne State Univ., Detroit, MI
Session: I C-Molecular and Cellular Biology of the Vessel Wall
T Cell Functions in a Novel Antigen-specific Experimentally-induced Model of Atherosclerosis
Dr. Heather Gornik, FAHA
Cleveland Clinic, Cleveland, OH
Session: D-Contemporary Management of Peripheral Arterial Disease
Comprehensive Care of the PAD Patient: Incorporating the Latest Evidence and Practice Guidelines into Clinical Vascular Practice
Anne Eichmann, PhD, MSc
Yale Univ. School of Medicine, New Haven, CT
II-Genetic and Molecular Determinants of Angiogenesis and Lymphangiogenesis
Guiding Development of Blood and Lymphatic Vessels
Karolinka Inst., Stockholm, Sweden
Session: Aortic and Carotid Artery Disease
Array-based Profiling Reveals Biomarker and Therapeutic Potential for Different microRNAs in Patients with Symptomatic Carotid Stenosis
- PAD affects about 8.5 million Americans 40 years and older and is associated with significant morbidity and mortality. PAD prevalence is higher in older individuals and appears to dis¬proportionately affect African Americans.
- In 2010, there were 146,000 hospitalizations and about 13,850 deaths due to PAD.
- In the general population, only about 10% of people with PAD have the classic symptom of intermittent claudication.
- Among patients with established PAD, higher physical activity levels during daily life are associated with better overall survival rate, a lower risk of death because of CVD, and slower rates of functional decline.
- Learn more in Heart Disease & Stroke Statistics: 2013 Update